Annals of Oncology Advance Access published online on July 29, 2008
Annals of Oncology, doi:10.1093/annonc/mdn533
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Epidemiology of biliary tract cancers: an update
1 Istituto di Ricerche Farmacologiche Mario Negri, Milan
2 Istituto di Statistica Medica e Biometria G.A. Maccacaro, Università degli Studi di Milano, Milan, Italy
3 Cancer Epidemiology Unit and Cancer Registries of Vaud and Neuchatel, Institut de médecine sociale et préventive (IUMSP); Centre Hospitalier Universitaire Vaudois et, Université de Lausanne, Lausanne, Switzerland
4 International Agency for Research on Cancer, Lyon, France
* Correspondence to: Dr G. Randi ScD., Istituto di Ricerche Farmacologiche Mario Negri, Via La Masa, 19, 20156 Milan, Italy. Tel: +39-02-39014665; Fax: +39-02-33200231; E-mail: randi{at}marionegri.it
Background: Biliary tract cancer (BTC) is a rare cancer in Europe and North America, characterized by wide geographic variation, with high incidence in some areas of Latin America and Asia.
Materials and methods: BTC mortality and incidence have been updated according to recent data, using joinpoint regression analysis.
Results: Since the 1980s, decreasing trends in BTC mortality rates (age-standardized, world standard population) were observed in the European Union as a whole, in Australia, Canada, Hong Kong, Israel, New Zealand, and the United States, and high-risk countries such as Japan and Venezuela. Joinpoint regression analysis indicates that decreasing trends were more favorable over recent calendar periods. High-mortality rates are, however, still evident in central and eastern Europe (4–5/100 000 women), Japan (4/100 000 women), and Chile (16.6/100 000 women). Incidence rates identified other high-risk areas in India (8.5/100 000 women), Korea (5.6/100 000 women), and Shanghai, China (5.2/100 000 women).
Conclusions: The decreasing BTC mortality trends essentially reflect more widespread and earlier adoption of cholecystectomy in several countries, since gallstones are the major risk factor for BTC. There are, however, high-risk areas, mainly from South America and India, where access to gall-bladder surgery remains inadequate.
biliary tract cancer, epidemiology, gall-bladder cancer, incidence, mortality, risk factors
Received for publication April 24, 2008. Revision received June 24, 2008. Accepted for publication June 26, 2008.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
G. Tonini, M. E. Fratto, B. Vincenzi, and D. Santini Classification of biliary tract cancer (BTC): evaluation of all entities Ann. Onc., June 1, 2009; 20(6): 1148 - 1149. [Full Text] [PDF] |
||||
![]() |
G. Randi, M. Malvezzi, F. Levi, J. Ferlay, E. Negri, S. Franceschi, and C. La Vecchia Reply to Classification of biliary tract cancer (BTC): evaluation of all entities Ann. Onc., June 1, 2009; 20(6): 1149 - 1149. [Full Text] [PDF] |
||||
